Your browser doesn't support javascript.
loading
Selection criteria and method for deep inspiration breath-hold in patients with left breast cancer undergoing PMRT/IMRT.
Zhou, Yingying; Xu, Jinfeng; Xu, Fumin; Li, Yanning; Li, Huali; Pan, Lisheng; Li, Yang; Cao, Shuyi; Cai, Longmei; Yang, Lin; Chen, Bo; Wang, Hongmei.
Afiliación
  • Zhou Y; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Xu J; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Xu F; Perception Vision Medical Technology, Guangzhou, China.
  • Li Y; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Li H; School of Biomedical Engineering, Southern Medical University, Guangzhou, China.
  • Pan L; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Li Y; The First School of Clinical Medicine, Southern Medical University, Guangzhou, China.
  • Cao S; Department of Biochemistry and Molecular Biology, School of Basic Medical Science, Southern Medical University and Guangdong Provincial Key Laboratory of Single Cell Technology and Application, Guangzhou, China.
  • Cai L; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Yang L; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Chen B; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Wang H; Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Clin Transl Radiat Oncol ; 48: 100812, 2024 Sep.
Article en En | MEDLINE | ID: mdl-39044781
ABSTRACT

Purpose:

This study explored whether a free-breathing mean heart dose (FB-MHD) of 4 Gy is a reliable dose threshold for selecting left breast cancer patients after modified radical mastectomy suitable for deep inspiration breath-hold (DIBH) and developed anatomical indicators to predict FB-MHD for rapid selection. Materials and

methods:

Twenty-three patients with left breast cancer treated with DIBH were included to compare FB and DIBH plans. The patients were divided into the high-risk (FB-MHD ≥ 4 Gy) and low-risk (FB-MHD < 4 Gy) groups to compare dose difference, normal tissue complication probability (NTCP) and the DIBH benefits. Another 30 patients with FB only were included to analyze the capacity of distinguishing high-risk heart doses patients according to anatomical metrics, such as cardiac-to-chest Euclidean distance (CCED), cardiac-to-chest gap (CCG), and cardiac-to-chest combination (CCC).

Results:

All heart doses were significantly lower in patients with DIBH plans than in those with FB plans. Based on FB-MHD of 4 Gy cutoff, the heart dose, NTCP for cardiac death, and benefits from DIBH were significantly higher in the high-risk group than in the low-risk group. The CCED was a valid anatomical indicator with the largest area under the curve (AUC) of 0.83 and maintained 95 % sensitivity and 70 % specificity at the optimal cutoff value of 2.5 mm.

Conclusions:

An FB-MHD of 4 Gy could be used as an efficient dose threshold for selecting patients suitable for DIBH. The CCED may allow a reliable prediction of FB-MHD in left breast cancer patients at CT simulation.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Transl Radiat Oncol Año: 2024 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Clin Transl Radiat Oncol Año: 2024 Tipo del documento: Article País de afiliación: China